OpenAI Leads $252M Seed Round in Merge Labs: Sam Altman's Non-Invasive BCI Startup Emerges from Stealth to Challenge Neuralink

Category: Industry Trends

Excerpt:

On January 15, 2026, OpenAI announced its participation as the lead investor in Merge Labs' $252 million seed round, valuing the stealth-mode brain-computer interface (BCI) startup at $850 million. Co-founded by OpenAI CEO Sam Altman, Merge Labs is developing safe, high-bandwidth, non-invasive BCIs using ultrasound and molecular approaches instead of implanted electrodes. The collaboration includes joint work on scientific foundation models to accelerate neuroscience and device engineering, positioning Merge Labs as a direct rival to Elon Musk's Neuralink while aiming to create seamless, human-centered AI interaction.

The convergence of AI and human biology just got a massive $252 million vote of confidence — and it's coming straight from the top of OpenAI. Merge Labs emerged from stealth on January 15, 2026, with OpenAI writing the largest check in its seed round alongside Bain Capital, Valve co-founder Gabe Newell, and others. Co-founded by Sam Altman (who serves as a board member but not personal investor), the lab's mission is unambiguous: bridge biological and artificial intelligence to maximize human ability, agency, and experience through fundamentally new BCI architectures.

Non-Invasive Path to High-Bandwidth Neural Control

Unlike Neuralink's surgical electrode implants, Merge Labs bets on a radically different stack:

  • • Connect neurons using molecules rather than physical threads
  • • Transmit/receive data via deep-reaching ultrasound for broader, safer coverage
  • • Combine biology, advanced devices, and AI for consumer-friendly form factors

The goal? Restore lost abilities, support healthier brain states, deepen human connections, and unlock "superhuman" capabilities alongside advanced AI — all without cracking open the skull.

The Circular Synergy That's Raising Eyebrows

OpenAI's blog post frames BCIs as "an important new frontier" for natural, seamless AI interaction. High-bandwidth interfaces need AI operating systems to interpret noisy brain signals, adapt to individuals, and execute reliably — exactly where OpenAI's foundation models shine.

In return, successful Merge tech could become the ultimate input layer for ChatGPT: think → instant AI response. This creates a tight feedback loop: Merge drives more users to OpenAI's ecosystem, justifying the investment while Altman oversees both sides.

Team, Competition & Ethical Considerations

All-Star Founding Team

  • • Mikhail Shapiro (Caltech chemical engineering pioneer)
  • • Tyson Aflalo & Sumner Norman (Forest Neurotech experts)
  • • Alex Blania & Sandro Herbig (Tools for Humanity alumni)

A "decades rather than years" long-term journey.

Competitive Firestorm

Direct rivalry with Neuralink ($9B valuation) & Synchron ($345M raised, Nvidia collaboration). US BCI TAM pegged at $400B+ (medical + enhancement).

Ethical & Governance Ripples

Critics highlight Altman's dual role oversight. Deal underscores OpenAI's push for an integrated AI ecosystem spanning energy, bio, and hardware.

The Next Computing Paradigm: Brain-Native

OpenAI's lead investment in Merge Labs isn't just funding — it's a declaration that the next computing paradigm is brain-native. By backing non-invasive, high-bandwidth BCIs, OpenAI positions itself at the forefront of human-AI fusion, potentially turning "think it, do it" from sci-fi to everyday reality. While decades away from consumer scale, this seed round accelerates the timeline and intensifies the race to merge minds with machines — with Altman steering both the software and the neural hardware.

Key Project Metrics

  • Seed Funding: $252 Million
  • Launch Date: January 15, 2026
  • Core Tech: Non-Invasive Ultrasound BCI
  • Key Backers: OpenAI, Bain Capital, Gabe Newell
  • US BCI TAM: $400B+
  • Timeline: Decades to Consumer Scale
Tags： , , , , , , ,
FacebookXWhatsAppEmail